Szu‐Min Hsieh

4.1k total citations
162 papers, 2.6k citations indexed

About

Szu‐Min Hsieh is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Szu‐Min Hsieh has authored 162 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Infectious Diseases, 84 papers in Epidemiology and 26 papers in Virology. Recurrent topics in Szu‐Min Hsieh's work include HIV/AIDS drug development and treatment (40 papers), Pneumocystis jirovecii pneumonia detection and treatment (31 papers) and HIV/AIDS Research and Interventions (31 papers). Szu‐Min Hsieh is often cited by papers focused on HIV/AIDS drug development and treatment (40 papers), Pneumocystis jirovecii pneumonia detection and treatment (31 papers) and HIV/AIDS Research and Interventions (31 papers). Szu‐Min Hsieh collaborates with scholars based in Taiwan, United States and Australia. Szu‐Min Hsieh's co-authors include Shan‐Chwen Chang, Chien‐Ching Hung, Wang‐Huei Sheng, Mao-Yuan Chen, Hsin‐Yun Sun, Chin‐Fu Hsiao, Sung‐Ching Pan, Sui‐Yuan Chang, M.-Y. Chen and Po‐Ren Hsueh and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Szu‐Min Hsieh

160 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Szu‐Min Hsieh Taiwan 27 1.5k 1.3k 410 377 339 162 2.6k
C. Michelet France 29 1.1k 0.7× 1.1k 0.8× 200 0.5× 494 1.3× 238 0.7× 94 2.5k
Carmen Quereda Spain 32 1.6k 1.1× 1.8k 1.4× 960 2.3× 460 1.2× 359 1.1× 132 3.4k
Fredy Suter Italy 26 1.6k 1.1× 1.5k 1.2× 540 1.3× 658 1.7× 234 0.7× 77 2.8k
Francesco Chiodo Italy 31 1.5k 1.0× 1.0k 0.8× 275 0.7× 759 2.0× 399 1.2× 215 3.1k
Harald H. Kessler Austria 31 1.5k 1.0× 1.7k 1.3× 821 2.0× 259 0.7× 141 0.4× 157 3.5k
N. Singh United States 33 2.0k 1.4× 2.4k 1.8× 219 0.5× 152 0.4× 539 1.6× 90 3.5k
Laurent Cotte France 29 1.7k 1.1× 1.1k 0.8× 383 0.9× 1.0k 2.7× 240 0.7× 119 3.3k
Juan Ambrosioni Spain 22 1.0k 0.7× 1.0k 0.8× 144 0.4× 355 0.9× 159 0.5× 104 1.9k
Vincent Le Moing France 31 2.3k 1.6× 2.0k 1.5× 345 0.8× 706 1.9× 685 2.0× 137 3.8k
Daniel Vittecoq France 33 1.9k 1.3× 1.2k 0.9× 676 1.6× 1.2k 3.1× 264 0.8× 144 3.6k

Countries citing papers authored by Szu‐Min Hsieh

Since Specialization
Citations

This map shows the geographic impact of Szu‐Min Hsieh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Szu‐Min Hsieh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Szu‐Min Hsieh more than expected).

Fields of papers citing papers by Szu‐Min Hsieh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Szu‐Min Hsieh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Szu‐Min Hsieh. The network helps show where Szu‐Min Hsieh may publish in the future.

Co-authorship network of co-authors of Szu‐Min Hsieh

This figure shows the co-authorship network connecting the top 25 collaborators of Szu‐Min Hsieh. A scholar is included among the top collaborators of Szu‐Min Hsieh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Szu‐Min Hsieh. Szu‐Min Hsieh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Guan‐Jhou, Wen-Chi Huang, Kuan‐Yin Lin, et al.. (2025). Long-Term Evolution of Renal Function Among People with HIV who Received Tenofovir Alafenamide-Containing Antiretroviral Therapy. Infectious Diseases and Therapy. 14(3). 603–614. 1 indexed citations
2.
Huang, Yu‐Shan, Szu‐Min Hsieh, Feng‐Chiao Tsai, et al.. (2024). Serological responses to COVID-19 vaccination in patients with chronic liver diseases. Journal of the Formosan Medical Association. 1 indexed citations
3.
Ma, Weili, Wang-Da Liu, Hsin‐Yun Sun, et al.. (2024). Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan. Journal of Microbiology Immunology and Infection. 57(3). 426–436. 2 indexed citations
4.
Chen, Joseph C. Y., Chiao‐Ling Tsai, Chia‐Ter Chao, et al.. (2024). Serial changes of 99mTc- pyrophosphate uptake in patients with hereditary transthyretin amyloid cardiomyopathy treated with tafamidis. European Heart Journal. 45(Supplement_1).
5.
Chen, Kai‐Hsiang, Hsin‐Yun Sun, Yu‐Chung Chuang, et al.. (2023). Higher Serologic Responses of Early Syphilis to Single-dose Benzathine Penicillin G Plus Doxycycline Versus Single-dose Benzathine Penicillin G Alone Among People With HIV. Clinical Infectious Diseases. 79(5). 1308–1315. 9 indexed citations
7.
Cheng, Shu‐Hsing, Chia-En Lien, Szu‐Min Hsieh, et al.. (2022). A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV. Vaccines. 11(1). 18–18. 5 indexed citations
8.
Liu, Chen‐Hua, Hsin‐Yun Sun, Cheng‐Yuan Peng, et al.. (2022). Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study. Open Forum Infectious Diseases. 9(8). ofac348–ofac348. 10 indexed citations
11.
Cheng, Aristine, Szu‐Min Hsieh, Sung‐Ching Pan, et al.. (2019). The safety and immunogenicity of a cell-derived adjuvanted H5N1 vaccine – A phase I randomized clinical trial. Journal of Microbiology Immunology and Infection. 52(5). 685–692. 2 indexed citations
13.
Hsieh, Szu‐Min, Sung‐Ching Pan, Sui‐Yuan Chang, et al.. (2013). Differential Impact of Resistance-Associated Mutations to Protease Inhibitors and Nonnucleoside Reverse Transcriptase Inhibitors on HIV-1 Replication Capacity. AIDS Research and Human Retroviruses. 29(8). 1117–1122. 2 indexed citations
14.
Sheng, Wang‐Huei, Chien‐Ching Hung, Sui‐Yuan Chang, et al.. (2011). Differential Clinical and Virologic Impact of Hepatitis B Virus Genotypes B and C on HIV-Coinfected Patients Receiving Lamivudine-Containing Highly Active Antiretroviral Therapy. Clinical Infectious Diseases. 54(4). 548–555. 12 indexed citations
15.
Hsieh, Szu‐Min, et al.. (2009). Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility. SHILAP Revista de lepidopterología. 14 indexed citations
16.
Chang, Sui‐Yuan, M.-Y. Chen, Chien‐Nan Lee, et al.. (2008). Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan. Journal of Antimicrobial Chemotherapy. 61(3). 689–693. 26 indexed citations
17.
Ho, Ya‐Chi, Tiffany Ting‐Fang Shih, Yu‐Hui Lin, et al.. (2007). Osteonecrosis in Patients with Human Immunodeficiency Virus Type 1 Infection in Taiwan. Japanese Journal of Infectious Diseases. 60(6). 382–386. 11 indexed citations
18.
Hung, Chien‐Ching, et al.. (2005). Prevalence of Toxoplasma gondii infection and incidence of toxoplasma encephalitis in non-haemophiliac HIV-1-infected adults in Taiwan. International Journal of STD & AIDS. 16(4). 302–306. 12 indexed citations
19.
Chen, Mao-Yuan, Szu‐Min Hsieh, Wang‐Hwei Sheng, et al.. (2003). Response to efavirenz plus two nucleoside reverse-transcriptase inhibitors in patients with advanced stage human immunodeficiency virus-1 infection in Taiwan.. PubMed. 36(1). 10–4. 4 indexed citations
20.
Hsieh, Szu‐Min, et al.. (1996). Concomitant human immunodeficiency virus infection and syphilitic meningitis.. PubMed. 95(2). 166–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026